Boston Scientific, Edwards Lifesciences Face Off in New TAVR Battle

A new patent spat is being fought in Germany by Boston Scientific (NYSE:BSX), who alleges that Edwards Lifesciences (NYSE:EW) is infringing on a patent associated with its Lotus transcatheter heart valve.

Late last month, Boston Scientific filed the patent infringement in Dusseldorf, Germany, charging that Edwards Sapien 3 transcatheter aortic valve replacement is infringing on a European adaptive sealing technology patent, according to a correspondence between MDDIOnline and Boston Scientific spokesperson Thomas Keppler.

Help employers find you! Check out all the jobs and post your resume.

Back to news